Skip to main content

Table 2 Features of the metabolic syndrome in patients with and without elevated liver aminotransferases

From: Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound

  Diabetic patients   
Variables (n, %) without increased
ALT
(n = 479)
with increased
ALT
(n = 191)
Crude OR
(95% CI)
Adjusted OR
(95% CI)
High blood pressure 203 (42.4) 91 (47.6) 1.24 (0.88-1.73) 1.11 (0.68-1.80) 1
High triglycerides 286 (59.7) 135 (70.7) 1.63 (1.13-2.33)* 1.50 (0.91-2.48) 1
Low HDL-C 256 (53.4) 133 (69.6) 2.00 (1.40-2.58)*** 2.04 (1.24-3.38) **1
High waist circumference 368 (26.8) 171 (89.5) 2.56 (1.53-4.26)*** 2.48 (1.20-5.11) *1
MetS 341 (71.2) 161 (84.3) 2.17 (1.40-3.36)*** 2.08 (1.12-3.87) *1
  without increased
AST
(n = 576)
with increased
AST
(n = 94)
  
High blood pressure 249 (43.2) 45 (47.9) 1.21 (0.78-1.87) 1.05 (0.56-1.98) 2
High triglycerides 354 (61.4) 67 (71.3) 1.56 (0.97-2.51) 1.39 (0.71-2.73) 2
Low HDL-C 320 (55.6) 69 (73.4) 2.21 (1.36-3.59)** 2.13 (1.06-4.31) *2
High waist circumference 405 (70.3) 84 (89.4) 2.23 (1.12-4.43)* 2.17 (0.89-5.31) 2
MetS 421 (73.1) 81 (86.2) 2.31 (1.25-4.27)** 2.23 (1.09-4.57) *2
  1. *P < 0.05, **P < 0.01, ***P < 0.001
  2. 1Adjusted for age, sex, BMI, diabetes duration, HbA1c and medications (anti diabetic, lipid lowering or antihypertensive agents)
  3. 2Adjusted for age, sex, BMI, diabetes duration, HbA1c and medications (anti diabetic, lipid lowering or antihypertensive agents)